Physician
Avenue U Medical Care PC
Avenue U Medical Care PC was paid $4.92M by Medicaid between Jan 2018 and Dec 2024, across 40 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 38% of everything it billed.
33Billing provider infoAVENUE U MEDICAL CARE PC
BROOKLYN, NY 11223
BROOKLYN, NY 11223
33aNPI1225440068assigned 05/28/2014
33bProvider typeDiagnostic Radiology Physician
28Total paid$4.92M
24GClaims157,244
24DCodes billed40
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Diagnostic Radiology Physician providers in New York
Rank by total paid#13 of 1,568
Median peer was paid$5K
This provider vs. median908×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 12,144 | $369K | |
| 2019 | 13,602 | $403K | |
| 2020 | 19,604 | $592K | |
| 2021 | 36,141 | $1.15M | |
| 2022 | 31,899 | $1.08M | |
| 2023 | 26,997 | $905K | |
| 2024incomplete | 16,857 | $416K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 38% | 35,283 | 24,876 | $1.88M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 37% | 33,553 | 25,982 | $1.80M |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 8.3% | 12,405 | 10,276 | $410K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 4.9% | 9,098 | 7,819 | $239K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.6% | 7,836 | 5,655 | $127K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.4% | 2,728 | 2,385 | $70K |
| 99051 | 1.4% | 7,874 | 7,139 | $68K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.3% | 9,661 | 9,021 | $66K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.3% | 4,385 | 3,783 | $66K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | <1% | 1,277 | 1,272 | $39K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 509 | 333 | $18K |
| 93000 | <1% | 1,254 | 1,162 | $17K |
28 more codes
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 565 | $15K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 199 | $14K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 155 | $11K |
| 36415 | Collection of venous blood by venipuncture | <1% | 10,712 | $11K |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 3,415 | $9K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 452 | $9K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 4,062 | $7K |
| 81002 | <1% | 4,327 | $7K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 102 | $5K |
| 86769 | <1% | 194 | $4K | |
| 82947 | <1% | 1,817 | $4K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 301 | $3K |
| 90674 | <1% | 145 | $3K | |
| 0011A | <1% | 78 | $3K | |
| 0031A | <1% | 80 | $2K | |
| 0001A | <1% | 58 | $2K | |
| M0222 | Intravenous injection, bebtelovimab, includes injection and post administration monitoring | <1% | 13 | $2K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,053 | $2K |
| 87807 | <1% | 487 | $2K | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 1,527 | $2K |
| 69210 | <1% | 61 | $1K | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 618 | $529.50 |
| J1940 | Injection, furosemide, up to 20 mg | <1% | 729 | $304.30 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 110 | $170.91 |
| 99348 | <1% | 30 | $69.96 | |
| 87070 | <1% | 16 | $40.16 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 55 | $32.94 |
| 91300 | <1% | 20 | $3.25 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFARIWA, VICTOR (PROVIDER)
| Provider | Location | Paid |
|---|---|---|
| Ave U Medical Care PC | Brooklyn, NY | $6K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.